SCHEMBL6999622

SCHEMBL6999622

CCOC(=O)C(C)Oc1ccc2c(c1[N+](=O)[O-])CCC(=O)C2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.38
KDM4E B2RXH2 7/20 0.38
HPGD P15428 5/20 0.38
TSHR P16473 4/20 0.38
NPSR1 Q6W5P4 3/20 0.38
HSD17B10 Q99714 3/20 0.38
MAPT P10636 3/20 0.38
ALOX15 P16050 1/20 0.38
MAPK1 P28482 1/20 0.38
NR5A1 Q13285 1/20 0.37
KMT2A Q03164 4/20 0.37
MEN1 O00255 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.34
HTT P42858 1/20 0.34
LMNA P02545 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
PPOX P50336 1/20 0.32
NPC1 O15118 1/20 0.32
NPBWR1 P48145 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6993231 0.91 ALDH1A1 (0.38) ALDH1A1KDM4EHPGDTSHRNPSR1
SCHEMBL6994414 0.85 ALDH1A1 (0.44) ALDH1A1KDM4EHPGDTSHRNPSR1
SCHEMBL7000166 0.85 ALDH1A1 (0.42) ALDH1A1KDM4EHPGDTSHRNPSR1
SCHEMBL8113280 0.83 MEN1 (0.37) ALDH1A1KDM4EHPGDTSHRNPSR1
SCHEMBL6998270 0.78 MEN1 (0.43) ALDH1A1KDM4EHPGDTSHRNPSR1
SCHEMBL7713466 0.73 MEN1 (0.40) ALDH1A1KDM4EHPGDTSHRNPSR1
SCHEMBL7704925 0.73 MEN1 (0.40) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL2059349 0.68 ALDH1A1 (0.48) ALDH1A1KDM4EHPGDTSHRNPSR1
SCHEMBL2062200 0.68 KDM4E (0.43) ALDH1A1KDM4EHPGDMAPTKMT2A
SCHEMBL6999500 0.68 ALDH1A1 (0.42) ALDH1A1KDM4EHPGDTSHRNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1015437-B1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AG (DE) 2003-12-03 EP disclosed
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed
EP-1015437-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 2000-07-05 EP disclosed
WO-1999012915-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 1999-03-18 WO disclosed